Skip to main content

MoonLake Immunotherapeutics

MLTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001821586

In the last 90 days, MoonLake Immunotherapeutics insiders filed 0 open-market purchases and 6 sales; 172 institutions reported holding it in 13F filings for Q2 2026, worth $1.43B in total; no superinvestor holds it.

13F holders, Q2 2023

Institutional positions in MoonLake Immunotherapeutics as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
83
+40 vs. Q1 2023
Shares held
56.1M
+16.6M (+42.2%) vs. Q1 2023
Total value
$2.86B
+$2.02B (+239.1%) vs. Q1 2023
New holders
47
25 more added
Sold out
7
8 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting MLTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 83 institutions
Q1 2021: 42 institutionsQ2 2021: 46 institutionsQ3 2021: 43 institutionsQ4 2021: 45 institutionsQ1 2022: 27 institutionsQ2 2022: 23 institutionsQ3 2022: 24 institutionsQ4 2022: 33 institutionsQ1 2023: 43 institutionsQ2 2023: 83 institutionsQ3 2023: 118 institutionsQ4 2023: 125 institutionsQ1 2024: 114 institutionsQ2 2024: 111 institutionsQ3 2024: 109 institutionsQ4 2024: 116 institutionsQ1 2025: 136 institutionsQ2 2025: 130 institutionsQ3 2025: 134 institutionsQ4 2025: 130 institutionsQ1 2026: 147 institutionsQ2 2026: 172 institutions
Value heldQ2 2023: $2.86B
Q1 2021: $108.9MQ2 2021: $115.8MQ3 2021: $111.1MQ4 2021: $112.8MQ1 2022: $123.4MQ2 2022: $190.1MQ3 2022: $291.4MQ4 2022: $396.4MQ1 2023: $843.2MQ2 2023: $2.86BQ3 2023: $3.21BQ4 2023: $3.53BQ1 2024: $2.99BQ2 2024: $2.67BQ3 2024: $3.14BQ4 2024: $3.43BQ1 2025: $2.34BQ2 2025: $2.77BQ3 2025: $269.7MQ4 2025: $742.9MQ1 2026: $1.17BQ2 2026: $1.43B
Institutions holding MLTX and their total value by quarter
QuarterHoldersValue
Q2 2026172$1.43B
Q1 2026147$1.17B
Q4 2025130$742.9M
Q3 2025134$269.7M
Q2 2025130$2.77B
Q1 2025136$2.34B
Q4 2024116$3.43B
Q3 2024109$3.14B
Q2 2024111$2.67B
Q1 2024114$2.99B
Q4 2023125$3.53B
Q3 2023118$3.21B
Q2 202383$2.86B
Q1 202343$843.2M
Q4 202233$396.4M
Q3 202224$291.4M
Q2 202223$190.1M
Q1 202227$123.4M
Q4 202145$112.8M
Q3 202143$111.1M
Q2 202146$115.8M
Q1 202142$108.9M

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding MoonLake Immunotherapeutics; share changes are against Q1 2023.

Institutions holding MLTX in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Allianz Asset Management GmbH4,400$2240.00%+4,400New
Private Trust Co NA34$1.73K0.00%+34New
New York State Common Retirement Fund165$8.41K0.00%+165New
Citigroup Inc603$30.8K0.00%−76,673−99.2%Reduced
Advisor Group Holdings, Inc.803$41.0K0.00%+727+956.6%Added
Tower Research Capital LLC (TRC)912$46.5K0.00%+912New
Dorsey Wright & Associates1,111$56.7K0.02%+111+11.1%Added
Virtus ETF Advisers LLC4,053$206.7K0.12%+4,053New
The PNC Financial Services Group, Inc.4,327$220.7K0.00%+4,327New
Envestnet Asset Management Inc5,098$260.0K0.00%+5,098New
LPL Financial LLC6,095$310.8K0.00%+6,095New
Wedbush Securities Inc6,890$351.0K0.02%+6,890New
Connor, Clark & Lunn Investment Management Ltd.9,421$480.5K0.00%+9,421New
Shay Capital LLC9,500$484.5K0.17%+9,500New
ArrowMark Colorado Holdings LLC10,000$510.0K0.01%+10,000New
Tudor Investment Corp Et Al13,549$691.0K0.01%+13,549New
Gilder Gagnon Howe & Co LLC15,047$767.4K0.01%+15,047New
Renaissance Technologies LLC15,500$791.0K0.00%−7,200−31.7%Reduced
SVB Financial Group16,173$824.8K1.56%00.0%Unchanged
Royal Bank of Canada20,196$1.03M0.00%+19,540+2,978.7%Added
EAM Investors, LLC20,917$1.07M0.20%+20,917New
Victory Capital Management Inc20,950$1.07M0.00%+20,950New
TimesSquare Capital Management, LLC30,000$1.53M0.02%+30,000New
Geode Capital Management, LLC31,968$1.63M0.00%+14,859+86.8%Added
Voya Investment Management LLC35,090$1.79M0.00%+35,090New
Ergoteles LLC38,617$1.97M0.09%+38,617New
Squarepoint Ops LLC41,431$2.11M0.01%+41,431New
Bank of America Corp42,657$2.18M0.00%+32,377+315.0%Added
Woodline Partners LP49,479$2.52M0.03%+49,479New
Monashee Investment Management LLC50,000$2.55M0.61%+50,000New
Velan Capital Investment Management LP55,300$2.82M2.65%+31,900+136.3%Added
Alyeska Investment Group, L.P.57,347$2.92M0.02%+57,347New
Marshall Wace, LLP58,383$2.98M0.01%+58,383New
Hudson Bay Capital Management LP60,000$3.06M0.03%+60,000New
Manufacturers Life Insurance Company, The62,737$3.20M0.00%+14,187+29.2%Added
Balyasny Asset Management LLC69,341$3.54M0.01%−128,366−64.9%Reduced
Granahan Investment Management Inc71,934$3.67M0.11%−1,703−2.3%Reduced
Parkman Healthcare Partners LLC80,000$4.08M0.71%+80,000New
Altium Capital Management LP88,000$4.49M3.51%+88,000New
Goldman Sachs Group Inc89,501$4.56M0.00%+89,501New
Ally Bridge Group (NY) LLC91,413$4.66M5.65%+18,563+25.5%Added
Jefferies Financial Group Inc.93,789$4.78M0.10%+24,076+34.5%Added
TD Asset Management Inc99,640$5.08M0.01%+32,328+48.0%Added
Deep Track Capital, LP108,450$5.53M0.26%+108,450New
OrbiMed Advisors LLC117,000$5.97M0.12%+117,000New
Schonfeld Strategic Advisors LLC117,960$6.02M0.05%+80,760+217.1%Added
HighVista Strategies LLC129,722$6.62M3.03%+7,521+6.2%Added
Nuveen Asset Management, LLC140,000$7.14M0.00%+140,000New
AXA S.A.154,932$7.90M0.03%−146,422−48.6%Reduced
Morgan Stanley159,425$8.13M0.00%+126,906+390.3%Added
Sectoral Asset Management Inc184,590$9.41M1.57%+184,590New
Millennium Management LLC192,404$9.81M0.01%+157,333+448.6%Added
Lord, Abbett & Co. LLC194,703$9.93M0.03%+194,703New
Silverarc Capital Management, LLC200,000$10.2M3.44%+94,250+89.1%Added
Franklin Resources Inc200,000$10.2M0.00%+200,000New
Invesco Ltd.261,860$13.4M0.00%+85,090+48.1%Added
MPM Oncology Impact Management LP295,111$15.1M3.03%+295,111New
JPMorgan Chase & Co298,178$15.2M0.00%−5,044−1.7%Reduced
Integral Health Asset Management, LLC300,000$15.3M2.01%+300,000New
Finepoint Capital LP302,000$15.4M5.33%+302,000New
Ghost Tree Capital, LLC330,000$16.8M6.07%+135,000+69.2%Added
5AM Venture Management, LLC357,486$18.2M4.54%+318,630+820.0%Added
Paradigm Biocapital Advisors LP369,615$18.9M1.53%+369,615New
Artal Group S.A.400,000$20.4M0.65%+400,000New
Avidity Partners Management LP400,000$20.4M0.71%+400,000New
Westfield Capital Management Co LP410,119$20.9M0.13%+410,119New
Wellington Management Group LLP413,269$21.1M0.00%+413,269New
RTW Investments, LP500,000$25.5M0.49%00.0%Unchanged
Banque Pictet & Cie SA640,000$32.6M0.29%+640,000New
BlackRock Inc.657,534$33.5M0.00%+542,604+472.1%Added
Fred Alger Management, LLC747,605$38.1M0.19%+640,685+599.2%Added
Alliancebernstein L.P.837,759$42.7M0.02%+837,759New
Pictet Asset Management SA894,005$45.6M0.05%+894,005New
T. Rowe Price Investment Management, Inc.1,148,809$58.6M0.04%+1,148,809New
Federated Hermes, Inc.1,169,499$59.6M0.15%+365,000+45.4%Added
Adage Capital Partners GP, L.L.C.1,372,328$70.0M0.15%−296,543−17.8%Reduced
Polar Capital Holdings Plc1,615,389$82.4M0.56%+739,012+84.3%Added
Avoro Capital Advisors LLC1,725,000$88.0M1.19%+1,725,000New
Price T Rowe Associates Inc1,943,056$99.1M0.01%+1,112,150+133.8%Added
Citadel Advisors LLC2,020,608$103.1M0.11%−902,830−30.9%Reduced
FMR LLC3,377,745$172.3M0.01%+2,902,313+610.5%Added
Cormorant Asset Management, LP8,142,100$415.2M23.65%+1,249,999+18.1%Added
BVF Inc21,751,284$1.11B30.92%00.0%Unchanged
Great Point Partners LLC0$00.00%−278,334−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−59,858−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−29,748−100.0%Sold out
Jane Street Group, LLC0$00.00%−26,034−100.0%Sold out
Boulder Hill Capital Management LP0$00.00%−14,500−100.0%Sold out
Ensign Peak Advisors, Inc0$00.00%−11,575−100.0%Sold out
UBS Group AG0$00.00%−7,960−100.0%Sold out